SAN DIEGO, Jan. 24 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Kim Blickenstaff, Biosite's chairman and
chief executive officer, and Ken Buechler, Ph.D., president and chief
scientific officer, will discuss the company's current operating environment
and business strategy at the Piper Jaffray Health Care Conference in New York,
January 27, 2004, at 12:00 p.m. Eastern.
A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on the
website for 28 days in the Investor and Media section, under Events Calendar.
A leader in the drive to advance diagnosis, Biosite Incorporated is a
research-based company dedicated to the discovery and development of novel
protein-based diagnostics that improve a physician's ability to diagnose
debilitating and life-threatening diseases. Biosite's Triage(R) rapid
diagnostics are used in approximately 50 percent of U.S. hospitals and in more
than 50 international markets for toxicology screening and diagnosis of
infectious and cardiovascular disease. Information on Biosite can be found at
http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-455-4808, ext.
3187, npadilla@biosite.com
|
